1. 1080. Relebactam Increases Imipenem Activity Against Imipenem-Nonsusceptible and -Susceptible Pseudomonas aeruginosa and Enterobacterales: Assessment of Isolates from RESTORE-IMI 2. (4th December 2021) Authors: Hilbert, David W; Andrew DeRyke, C; Losada, Maria C; Moise, Pamela; Chen, Luke F; Young, Katherine Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1080. Relebactam Increases Imipenem Activity Against Imipenem-Nonsusceptible and -Susceptible Pseudomonas aeruginosa and Enterobacterales: Assessment of Isolates from RESTORE-IMI 2. (4th December 2021) Authors: Hilbert, David W; Andrew DeRyke, C; Losada, Maria C; Moise, Pamela; Chen, Luke F; Young, Katherine Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection. (4th December 2021) Authors: Bauer, Karri A; Hidayat, Levita K; Klinker, Kenneth; Motyl, Mary; Andrew DeRyke, C Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1273. Activity of Ceftolozane/Tazobactam and Comparators Against Enterobacterales and P. aeruginosa Isolates from Pediatric Patients—SMART United States 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1273. Activity of Ceftolozane/Tazobactam and Comparators Against Enterobacterales and P. aeruginosa Isolates from Pediatric Patients—SMART United States 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1274. Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, and Comparators Against Pseudomonas aeruginosa Isolates from Patients with Bloodstream and Other Infection Types—SMART United States/Canada 2018-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1274. Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, and Comparators Against Pseudomonas aeruginosa Isolates from Patients with Bloodstream and Other Infection Types—SMART United States/Canada 2018-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1294. Activity of Ceftolozane/Tazobactam and Comparators against Resistant Pseudomonas aeruginosa Isolates from Patients with Respiratory Tract or Bloodstream Infections in ICU and non-ICU settings – SMART United States 2018-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Harris, Kelly; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 1295. Susceptibility to Ceftolozane/Tazobactam and Comparators Among Pseudomonas aeruginosa Isolates Collected from Patients in Hospitals in Latin America – SMART 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Pavía, Jacquleine; Siddiqui, Fakhar; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 1295. Susceptibility to Ceftolozane/Tazobactam and Comparators Among Pseudomonas aeruginosa Isolates Collected from Patients in Hospitals in Latin America – SMART 2017-2019. (4th December 2021) Authors: Lob, Sibylle; Hackel, Meredith; Andrew DeRyke, C; Pavía, Jacquleine; Siddiqui, Fakhar; Young, Katherine; Motyl, Mary; Sahm, Daniel F Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗